I recommended our paid members sell their Aurora Cannabis (NYSE: ACB) and Elixinol Global (OTC: ELLXF) holdings. I am no longer confident in either company’s ability to weather a sustained downturn.
Elixinol is facing similar issues, and the company’s U.S. expansion has been a disappointment.
I’m disappointed that these stocks have done so poorly. But I feel it’s best that we cut our losses. It’s possible that these companies will rebound. But I believe they no longer offer an attractive risk-reward proposition.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.